Reviews represent individual experiences and may not reflect typical results
This signals a significant escalation in the FDAs oversight of the rapidly expanding weight-loss drug market and marks a second wave of enforcement following the Agencys broader crackdown on pharmaceutical direct-to-consumer (DTC) advertising
The NIH's own overview of weight-management medications, linked from the brand's comparison page, is a useful independent starting point for readers who want to look at the underlying drug-class research separately from Telos Rx's own patient-reported numbers
The safety profile of retatrutide was similar to that of GLP-1 receptor agonists, with transient gastrointestinal events being the most frequently reported side effects
Kardashian first launched her Lemme wellness brand in the fall of 2022 with three products: Lemme Matcha, Lemme Chill and Lemme Focus
Future outlook Research into GLP-1 patches is progressing quickly, with several pharmaceutical companies reporting positive results from preclinical and early human studies